首页 › 非小细胞肺癌 › 加利福尼亚州 › Baldwin Park
Baldwin Park CA 非小细胞肺癌临床试验
36项针对 非小细胞肺癌的研究正在 Baldwin Park及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
招募中3 期
- City of Hope /ID# 243157, Duarte · 距离 4 英里
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
招募中2/3 期
- City of Hope National Medical Center /ID# 277005, Duarte · 距离 4 英里
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
招募中3 期
- Kaiser Permanente-Baldwin Park, Baldwin Park
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
招募中1 期
- City of Hope National Medical Center, Duarte · 距离 4 英里
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
招募中2 期
- City of Hope, Duarte · 距离 4 英里
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
招募中1 期
- City of Hope Comprehensive Cancer Center, Duarte · 距离 4 英里
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
招募中1 期
- City of Hope National Medical Center, Duarte · 距离 4 英里
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
招募中1 期
- Research Site, Duarte · 距离 4 英里
A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC
招募中2 期
- City of Hope, Duarte · 距离 4 英里
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
招募中2 期
- City of Hope, Duarte · 距离 4 英里
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
招募中1 期
- Research Site, Duarte · 距离 4 英里
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
招募中1 期
- City of Hope Cancer Center, Duarte · 距离 4 英里
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
招募中1 期
- City of Hope, Duarte · 距离 4 英里
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
招募中1/2 期
- City of Hope - Duarte Cancer Center, Duarte · 距离 4 英里
A Study of KK2269 in Adult Participants With Solid Tumors
招募中1 期
- City Of Hope National Medical Center, Duarte · 距离 4 英里
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
招募中3 期
- Research Site, Duarte · 距离 4 英里
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
招募中1/2 期
- City of Hope, Duarte · 距离 4 英里
Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma
招募中2 期
- City of Hope Medical Center, Duarte · 距离 4 英里
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
招募中1 期
- City of Hope, Duarte · 距离 4 英里
A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab
招募中1 期
- City of Hope Medical Center, Duarte · 距离 4 英里
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
招募中1 期
- City of Hope National Medical Center, Duarte · 距离 4 英里
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
招募中1/2 期
- City of Hope, Duarte · 距离 4 英里
AOH1996 for the Treatment of Refractory Solid Tumors
招募中1 期
- City of Hope Medical Center, Duarte · 距离 4 英里
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
招募中1 期
- City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte · 距离 4 英里
- IP Address: City of Hope Investigational Drug Services(IDS), Duarte · 距离 4 英里
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
招募中3 期
- City of Hope Comprehensive Cancer Center, Duarte · 距离 4 英里
Evaluation of Geriatric Assessment and Management for Older Adults With Non-small Cell Lung Cancer Receiving Chemotherapy Radiation Therapy
招募中欢迎健康志愿者
- City of Hope Medical Center, Duarte · 距离 4 英里
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
招募中1/2 期
- City of Hope - Duarte, Duarte · 距离 4 英里
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
招募中1 期
- City of Hope National Medical Center /ID# 276272, Duarte · 距离 4 英里
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
招募中1 期
- Research Site, Duarte · 距离 4 英里
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
招募中2/3 期
- Kaiser Permanente-Baldwin Park, Baldwin Park
- City of Hope Comprehensive Cancer Center, Duarte · 距离 4 英里
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
招募中
- Beckman Research Institute of City of Hope, Duarte · 距离 4 英里
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
招募中2 期
- City of Hope Medical Center, Duarte · 距离 4 英里
Carfilzomib in Combination With Sotorasib for the Treatment of Patients With KRAS G12C Mutated Advanced or Metastatic Non-small Cell Lung Cancer
招募中1 期
- City of Hope Medical Center, Duarte · 距离 4 英里
Phase II Trial of Lung Chemoemobolization
招募中2 期
- City of Hope Medical Center, Duarte · 距离 4 英里
Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer
招募中2 期
- City of Hope Medical Center, Duarte · 距离 4 英里
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Duarte · 距离 4 英里
其他城市的 非小细胞肺癌试验
- Houston, TX145 项研究
- New York City, NY121 项研究
- Arlington, VA104 项研究
- Nashville, TN97 项研究
- Boston, MA90 项研究
- Los Angeles, CA87 项研究
- St. Louis, MO73 项研究
- Chicago, IL61 项研究
- Baltimore, MD60 项研究
- San Antonio, TX59 项研究
- Columbus, OH57 项研究
- Washington, DC55 项研究
Baldwin Park的其他研究
- 乳腺癌44 项研究
- 急性髓系白血病40 项研究
- 结直肠癌37 项研究
- 癌症（所有类型）34 项研究
- 前列腺癌30 项研究
- 转移性癌症30 项研究
- 骨髓增生异常综合征26 项研究
- 卵巢癌25 项研究
- 肺癌24 项研究
- 多发性骨髓瘤23 项研究
- 胃癌22 项研究
- 急性淋巴细胞白血病21 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。